Multidisciplinary Care Approaches For Patients With Ehlers-Danlos Syndrome
Published on: October 10, 2025
Multidisciplinary Care Approaches For Patients With Ehlers-Danlos Syndrome
Article author photo

DR PAROMITA GUHA

Bachelor of Dental Surgery (2009)

Article reviewer photo

Zuhra Ahmad

Bachelor in pharmaceutical sciences with regulatory affairs

Overview

The Ehlers-Danlos syndromes (EDSs) were originally described by Ehlers in Denmark and Danlos in Paris in the years 1898 and 1908, respectively. Both researchers published individual case studies in which the common factors were loose ligaments leading to excessively flexible joints and unusually stretchy skin. The name of this disease was given by Dr Parkes Weber, an eminent London physician, in the 1930s. In the year 1891, Tchernabogov, a Russian dermatologist, provided the best descriptions of EDS, which remain the best in the literature.1

The EDS is a genetic condition. It affects both males and females equally, although most symptomatic patients are female. At present, there are 13 different subtypes of EDS. EDS affects approximately 1 in 5000 to 1 in 20,000 people worldwide, with hypermobile Ehlers–Danlos syndrome (hEDS) being the most common subtype.3,2

Keep overview brief. “EDS was first described in the late 19th century and named in the 1930s. It is a rare genetic connective tissue disorder affecting ~1 in 5,000–20,000 people worldwide, with 13 recognised subtypes. Hypermobile EDS (hEDS) is the most common.”

What is ehlers-danlos syndrome (EDS)? 

If your body does not make or use collagen, fibrillin or elastin, you are a patient with Ehlers-Danlos syndrome (EDS). Your gut, heart, blood vessels, muscles and joints will get severely affected. You will experience as very fragile skin, abnormal functioning of organs, widespread pain, and overly flexible joints that can lead to repeated joint dislocations and other injuries.3

Make the definition more concise. Such as “EDS is a genetic disorder affecting collagen, elastin, or fibrillin synthesis and function, leading to fragile skin, hypermobile joints, chronic pain, and multi-organ involvement.”

Multidisciplinary care approaches for patients with ehlers-danlos syndrome

The multidisciplinary approach includes physiotherapy, occupational therapy, cognitive behavioural therapy, and pharmacological interventions to decrease pain, aid in daily activities, and boost confidence physically and mentally. 2

Your multidisciplinary team may include a physician (or several specialists), an occupational therapist, a physical therapist, a nurse, a dietitian, and a psychologist.3

Condense: “PT is central in hEDS. Evidence supports therapeutic exercise and motor training to improve strength, posture, and spinal stability.”

Physical therapy (PT) plays a central role in treating individuals with Hypermobile Ehlers-Danlos Syndrome (hEDS). Evidence found indicates that therapeutic exercise and motor function training are efficacious methods to treat individuals with HEDS.4 Exercise and rehabilitation for people with EDS usually aim to improve physical function by building muscle strength, balance, and posture. This often includes exercises for spinal stability and core endurance.3

Occupational therapy (OT) helps people stay independent in their daily activities. Occupational therapists are very important members of the care team. They provide practical solutions to improve comfort, independence, and participation in everyday life.5

Possible treatment interventions:6

  • Strengthening (stability, low and slow) 
  • Joint protection
  • Fatigue and energy management
    • Pacing
    • Energy conservation
    • Work simplification
  • Fine motor skills and hand function
    • Handwriting
    • Dressing, buttoning
  • Pain education and management
  • Sleep education and management
    • Sleep hygiene
    • Routines
  • Proprioception and body awareness 
  • Balance, postural sway 
  • Postural alignment
  • Interoception 
  • Sensory processing 
  • Ergonomic positioning and work setup
  • Work and school exploration, accommodations, and support 
  • Leisure and play pursuits
  • Social participation
  • Mental health support and coping skills
    • Validation 
    • Working toward acceptance
  • Health management
    • Increasing self-awareness of symptoms 
    • Pregnancy and post-partum considerations 
  • Self-advocacy skills 
  • Education
    • Condition pathophysiology
    • Exacerbating and relieving factors
    • Management
    • Co-occurring conditions as appropriate
    • How to find and gather information related to hEDS
  • Home program
    • Constant motivation, adapting to routines, watching out for benefits, and partnering with family/others encourages the patient to continue to exercise 

 Condense into categories:

  • Joint protection & mobility (splinting, orthotics, ergonomic positioning)
  • ADLs & function (handwriting, dressing, fatigue management)
  • Pain & fatigue management (education, pacing, sleep hygiene)
  • Psychosocial support (coping skills, self-advocacy, accommodations)

Cognitive behavioural therapy(CBT)- CBT is a type of therapy that helps people with chronic illness management of pain, disability, and mental health challenges by teaching coping skills.People with EDS experience physical problems that lead to psychiatric disorders such as depression and anxiety, along with social and emotional difficulties. Dialectical behavioural therapy (DBT) is a type of CBT that uses strategies such as mindfulness, stress management, and developing control over emotions to improve the patient’s quality of life. CBT methods include breathing techniques, positive self-talk, and distraction. Studies show that CBT can improve pain control and help patients manage daily activities more effectively.7

Condense: “CBT and DBT help patients manage chronic pain, disability, and mental health challenges through coping strategies, mindfulness, and emotional regulation.”

Pharmacologic interventions8-  No cure is available for EDS. Medications help in managing symptoms and complications like pain,  gut problems, and abnormalities in the functioning of the heart and blood vessels.

Chronic pain is a hallmark symptom of many EDS types.

Pain management involves:

  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs):  mild to moderate pain is managed by them, but they can increase the risk of gastrointestinal complications, a common concern in EDS
  • Tricyclic Antidepressants (TCAs) and Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): treatment of nerve pain is achieved by them. They can also be effective for addressing associated mental health concerns like depression​​
  • Opioids: mainly used for severe pain, opioids should be used cautiously due to the risk of drug dependency
  • Low-Dose Naltrexone (LDN): effective in reducing chronic pain and inflammation in EDS
  • Muscle Relaxants: EDS patients​ distressed with muscle spasms are provided relief with these medications

Many individuals with vascular EDS (vEDS) are at risk of cardiovascular complications such as high blood pressure, arterial rupture, or aneurysms. Medications used are

  • Beta-Blockers
  • Angiotensin Receptor Blockers (ARBs)
  • Celiprolol: this drug is used off-label in the U.S.  to treat Vascular EDS (vEDS). It is under evaluation for broader use​.

Gastrointestinal issues are common in EDS, which include issues such as irritable bowel syndrome (IBS), gastroparesis, and acid reflux:

  • Proton Pump Inhibitors (PPIs): Reduce stomach acid production in EDS, thus treating conditions like gastritis and  GERD in EDS. 
  • Laxatives: Bulk-forming laxatives or osmotic laxatives help manage constipation.

Chronic pain and the stress of living with a complex disorder like EDS can lead to mental health challenges, including anxiety and depression​. Treatment may involve:

  • Selective Serotonin Reuptake Inhibitors (SSRIs) manage anxiety and depression, both are common in EDS​​.
  • Tricyclic Antidepressants like amitriptyline are also used to manage chronic neuropathic pain​.

Restructure for clarity:

  • Pain management: NSAIDs, TCAs/SNRIs, opioids (cautious use), LDN, muscle relaxants
  • Cardiovascular (vEDS): beta-blockers, ARBs, celiprolol
  • Gastrointestinal: PPIs, laxatives
  • Mental health: SSRIs, TCAs (for pain + depression)

Summary

Though updated guidelines for treating chronic pain in EDS are lacking, clinicians focus on a conservative multidisciplinary approach in patients with EDS, which avoids surgical interventions and their accompanying risks of morbidity and mortality.2 Effective treatment often requires a multidisciplinary approach along with proper medication, lifestyle adjustments and physical therapy to improve quality of life​​. Always consult with healthcare providers before starting any new medication, as individualised care is critical in managing this complex condition.8

Condense: “EDS is a complex genetic connective tissue disorder requiring multidisciplinary management. Physical and occupational therapy, psychological interventions, and pharmacologic options are combined to address pain, functional impairment, and systemic complications. While no cure exists, individualised multidisciplinary care improves quality of life.”

References

  1. Grahame, R. ‘Ehlers-Danlos Syndrome’. South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde, vol. 106, no. 6 Suppl 1, May 2016, pp. S45-46. PubMed, https://doi.org/10.7196/SAMJ.2016.v106i6.10991.
  2. Whalen, Kiley C., and Wilson Crone. ‘Multidisciplinary Approach to Treating Chronic Pain in Patients with Ehlers-Danlos Syndrome: Critically Appraised Topic’. Journal of Pain Research, vol. 15, 2022, pp. 2893–904. PubMed, https://doi.org/10.2147/JPR.S377790.
  3. Buryk-Iggers, Stephanie, et al. ‘Exercise and Rehabilitation in People With Ehlers-Danlos Syndrome: A Systematic Review’. Archives of Rehabilitation Research and Clinical Translation, vol. 4, no. 2, Jun. 2022, p. 100189. ScienceDirect, https://doi.org/10.1016/j.arrct.2022.100189.
  4. Garreth Brittain, Mackenzie, et al. ‘Physical Therapy Interventions in Generalized Hypermobility Spectrum Disorder and Hypermobile Ehlers-Danlos Syndrome: A Scoping Review’. Disability and Rehabilitation, vol. 46, no. 10, May 2024, pp. 1936–53. DOI.org (Crossref), https://doi.org/10.1080/09638288.2023.2216028.
  5. Occupational Therapy’. The Ehlers-Danlos Society, https://www.ehlers-danlos.com/occupational-therapy/Accessed 21 Aug. 2025.
  6. OT for Hypermobile Ehlers-Danlos Syndrome (hEDS) and Hypermobility Spectrum Disorders (HSD) • OT Potential. 26 Jun. 2025, https://otpotential.com/treatment/ot-for-ehlers-danlos-syndrome.
  7. Song, Jessica Z., et al. ‘Psychological Interventions for Individuals with Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorder: A Scoping Review’. Orphanet Journal of Rare Diseases, vol. 18, Aug. 2023, p. 254. PubMed Central, https://doi.org/10.1186/s13023-023-02799-y.
  8. Medications for Ehlers-Danlos Syndrome Treatment | The EDS Clinic. https://www.eds.clinic/articles/medications-for-ehlers-danlos-syndrome-treatment. Accessed 22 Aug. 2025.

Share

DR PAROMITA GUHA

Bachelor of Dental Surgery (2009)

arrow-right